THE WHAT? Kenvue has reported first-quarter 2026 sales and earnings growth, supported by improved execution, innovation and margin expansion across its health and beauty portfolio.
THE DETAILS Kenvue reported a 4.5% increase in net sales for Q1 2026, with organic sales rising 0.7% and diluted earnings per share increasing 47% to US$0.25. Adjusted diluted EPS rose 33% to US$0.32. The company said improvements in gross profit and operating margins were driven by supply chain optimization initiatives, productivity gains and cost reduction programmes. Skin Health and Beauty delivered the strongest performance, with net sales increasing 8.4% and organic sales up 5%, supported by innovations including Neutrogena Sun Care expansion in EMEA and the launch of OGX Pro Growth. Essential Health sales rose 4.9%, driven by growth in Baby Care, Oral Care and Wound Care, while Self Care sales increased 1.9% despite weaker cold and flu seasons in major markets. Kenvue also confirmed progress on its planned acquisition by Kimberly-Clark, which is expected to close in the second half of 2026 pending regulatory approvals.
THE WHY? The results demonstrate continued resilience in the health, beauty and personal care sector despite macroeconomic uncertainty, while highlighting Kenvue’s focus on operational efficiencies, innovation and portfolio strengthening ahead of its merger with Kimberly-Clark.
Source: Kenvue
